Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Zimmer Biomet Holdings, Inc. (ZBH) a Sell on Lousy Earnings Growth

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the 783 companies in the GICS Health Care sector, and a constituent of the 162 company Health Care Equipment & Supplies GICS industry group within this sector. The market value of ZBH is $24.2 billion which places it in the top decile in its industry group. The current Portfolio Grader ranking for ZBH puts it 114 among the 162 companies in this industry group, which is a below-average position; in the third quartile of the sector with a ranking of 521 among the 783 companies in the sector, and number 3,460 in the nearly 5,000 company Portfolio Grader universe.

Baxter International (BAX) a Buy on Robust Quant Score

Portfolio Grader currently ranks Baxter International Inc (NYSE:BAX) a Buy. The methods for fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier researches and ranks nearly 5,000 stocks each week. BAX has maintained this ranking for 10 months.

Morgan Stanley (MS) Stock Pops on Stellar Q3 Earnings

Morgan Stanley (MS) stock got a boost today after reporting positive results in its earnings report for the third quarter of 2017.

Robust Quant Score Keeps Koninklijke Philips (PHG) a Buy

The current recommendation of Buy for Koninklijke Philips NV (NYSE:PHG) is the result of using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. PHG has maintained this ranking for 3 months.

Can the Cord Become a Stream for Walt Disney Co?

Disney is fighting the cord-cutting trend with its own streaming services, making DIS stock both a riskier and more promising investment.

Superb Analytics for Earnings Growth Make Intuitive Surgical (ISRG) a Strong Buy

Intuitive Surgical Inc (NASDAQ:ISRG) is ranked as a Strong Buy using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator. ISRG has maintained this ranking for 7 months.

Boston Scientific’s (BSX) Strong Quant Score Keeps it a Buy

Portfolio Grader currently ranks Boston Scientific (NYSE:BSX) a Buy. With exclusive fundamental and quantitative metrics developed by Louis Navellier, this analytical tool assesses nearly 5,000 stocks weekly. This represents no change from the previous week and is the same ranking BSX has had from Portfolio Grader for the last month.

Becton Dickinson & Co (BDX) a Buy on Robust Quant Score

Portfolio Grader currently ranks Becton Dickinson & Co (NYSE:BDX) a Buy. The methodology for fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier researches and ranks nearly 5,000 stocks each week. This represents no change from the previous week and is the same ranking BDX has had from Portfolio Grader for 5 months.

High-Level Quant Score Makes Stryker Corporation (SYK) a Strong Buy

As one of the 783 companies in the GICS Health Care sector Stryker Corporation (NYSE:SYK) is a constituent of the 162 company Health Care Equipment & Supplies GICS industry group within this sector. The market value of SYK is $54.9 billion which places it in the top 10% of its industry group. The stock's current Portfolio Grader score places it 14 among the 162 companies in this industry group, positioning it among the leaders; in the top decile of the sector with a ranking of 33 among the 783 companies in the sector, and number 320 in the nearly 5,000 company Portfolio Grader universe.

Earnings Momentum Hampers Danaher Corporation (DHR) Rating

Portfolio Grader currently ranks Danaher Corporation (NYSE:DHR) a Hold. With proprietary fundamental and quantitative metrics developed by Louis Navellier, this analytical tool assesses nearly 5,000 stocks weekly. The current Portfolio Grader recommendation on the shares has been in place for the last month.

Healthy Earnings Momentum Keeps Abbott Laboratories (ABT) a Buy

Portfolio Grader currently ranks Abbott Laboratories (NYSE:ABT) a Buy. Using Louis Navellier's investing system, this analytical tool assesses stocks with fundamental and quantitative metrics. This represents no change from the previous week and is the same ranking ABT has had from Portfolio Grader for the last month.

Here’s a Quick Solution to Nike Inc (NKE) Stock Troubles

Nike growth is slowing which is putting a crimp in NKE stock. Buying Lululemon would solve Nike's growth problem

Robust Earnings Visibility Makes Banco Santander (SAN) a Buy

Banco Santander SA (NYSE:SAN) is one of the 772 companies in the GICS Financials sector, and a member of the 346 company Banks GICS industry group within this sector. SAN has a market value of $97.6 billion which is in the top 10% of its industry group. Currently, the stock's Portfolio Grader ranking places it 54 among the 346 companies in this industry group, placing it among the leaders; in the top quartile of the sector with a ranking of 116 among the 772 companies in the sector, and number 546 in the nearly 5,000 company Portfolio Grader universe.

Medtronic (MDT) a Sell on Falling Industry Group Rank

Medtronic Plc (NYSE:MDT) is one of 162 companies within the Health Care Equipment & Supplies GICS industry group, which is in turn part of the 783 company GICS Health Care sector. MDT's market value is $105.8 billion which places it in the top 10% of its industry group. The ranking for MDT by Portfolio Grader places it 97 among the 162 companies in this industry group, giving it a lower than average position; in the third quartile of the sector with a ranking of 446 among the 783 companies in the sector, and number 3,085 in the nearly 5,000 company Portfolio Grader universe.

Royal Bank of Canada’s (RY) Healthy Quant Score Makes it a Buy

With a $115.6 billion market value, Royal Bank of Canada (NYSE:RY) ranks in the top 10% of its industry group, Banks, and in the top decile of sector group, Financials, in market value. From the prospective of investment attractiveness, Portfolio Grader's current ranking for RY puts it 70 among the 346 companies in this industry group, giving it a well above-average position; in the top quartile of the sector with a ranking of 153 among the 772 companies in the sector, and number 711 in the nearly 5,000 company Portfolio Grader universe.

Citigroup (C) a Buy on Strong Quant Score

The current recommendation of Buy for Citigroup Inc (NYSE:C) is the result of using Louis Navellier's investing approach and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 2 months.

HSBC Holdings plc Sponsored ADR (HSBC) a Buy on Healthy Earnings Visibility

Currently, HSBC Holdings plc Sponsored ADR (NYSE:HSBC) has a Buy using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing approach. The current Portfolio Grader recommendation on the shares has been in place for the last month.

Shares of Wells Fargo & Co (WFC) Reduced to Sell

Wells Fargo & Co (NYSE:WFC) is one of the 772 companies in the GICS Financials sector, and a member of the 346 company Banks GICS industry group within this sector. The market value of WFC is $264.6 billion which falls in the top 10% of its industry group. The stock's current Portfolio Grader ranking places it 291 among the 346 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 611 among the 772 companies in the sector, and number 3,191 in the nearly 5,000 company Portfolio Grader universe.

Bank of America’s (BAC) Strong Earnings Visibility Makes it a Buy

Bank of America Corp (NYSE:BAC) ranks in the top 10% of its industry group, Banks, and in the top 10% of its sector group, Financials, with a market value of $270.1 billion. From an investment attractiveness prospective, BAC is ranked in the top half of the sector with a ranking of 286 among the 772 companies in the sector; Portfolio Grader's current ranking for BAC puts it 136 among the 346 companies in this industry group, putting it in the second quartile and number 1,489 in the 5000 company Portfolio Grader company universe.